Relations between professional medical associations and the health-care industry, concerning scientific communication and continuing medical education: a Policy Statement from the European Society of Cardiology
Relations between professional medical associations and the health-care industry, concerning scientific communication and continuing medical education: a Policy Statement from the European Society of Cardiology
复制标题
DOI：
10.1093/eurheartj/ehr480
复制
发表时间：
2012-03-01
影响因子：
39.3
通讯作者：
Fraser, Alan G.
中科院分区：
文献类型：
--
作者：
Komajda, Michel;Ferrari, Roberto;Fraser, Alan G.
医生有道德义务保持与时俱进的知识。欧洲心脏病学会（ESC）等专业医学协会支持这些义务。在欧洲，继续医学教育（CME）的费用没有得到政府和雇主的充分支持;然而，医学协会因接受行业的替代财政支持而受到批评。医学教育和研究培训包括学习如何评估任何信息的质量和可靠性。任何形式的科学交流，包括知识、专业和财务交流，都存在一定程度的偏见风险，尤其是必须充分披露财务信息。学术机构的基础和临床研究人员与设备和制药公司研究部门的工程师和科学家之间的密切合作至关重要。这对于开发新的诊断方法和治疗方法至关重要。行业的进步可能会加速其在临床实践中的实施。大学现在经常派出学术人员保护他们的知识产权或使他们的研究商业化。因此，不是商业活动或联系本身成为批评的目标，而是商业企业对临床决策或专业医疗组织传达的信息的影响。本文件提供了ESC对当前辩论的观点，并建议如何最大限度地减少科学交流和继续医学教育中的偏见，以及如何确保医学专业和行业之间关系的适当道德标准和透明度。
Physicians have an ethical duty to keep up-to-date with current knowledge. Professional medical associations such as the European Society of Cardiology (ESC) support these obligations. In Europe, the costs of continuing medical education (CME) are insufficiently supported from governments and employers; however, medical associations have been criticized for accepting alternative financial support from industry. Medical education and training in research include learning how to assess the quality and reliability of any information. There is some risk of bias in any form of scientific communication including intellectual, professional, and financial and it is essential that in particular, the latter must be acknowledged by full disclosure. It is essential that there is strong collaboration between basic and clinical researchers from academic institutions on the one hand, with engineers and scientists from the research divisions of device and pharmaceutical companies on the other. This is vital so that new diagnostic methods and treatments are developed. Promotion of advances by industry may accelerate their implementation into clinical practice. Universities now frequently exhort their academic staff to protect their intellectual property or commercialize their research. Thus, it is not commercial activity or links per se that have become the target for criticism but the perceived influence of commercial enterprises on clinical decision-making or on messages conveyed by professional medical organizations. This document offers the perspective of the ESC on the current debate, and it recommends how to minimize bias in scientific communications and CME and how to ensure proper ethical standards and transparency in relations between the medical profession and industry.